Response to COVID-19 Vaccination in Adults with Hematologic Malignancies Compared to Patients with HIV and Solid Tumors: Observations from A Single Tertiary Institution
Year: 2023
Type: article
Study design: Observational Study
Abstract: By Bowen He, Prakash Vishnu & 2 more. This study analyzes seroconversion rates following a primary two-dose COVID-19 vaccination series and subsequent seroconversion rates after booster doses across our patient population with HM, HIV infection and solid tumors
DOI: 10.53876/001c.73728
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4360602088
